Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Soligenix
BrandsSoligenix

How AI describes Soligenix

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Soligenix logoSoligenixsoligenix.com · Low evidence
Low evidence

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with unmet medical needs. Its Specialized BioTherapeutics pipeline includes HyBryte for Cutaneous T-Cell Lymphoma, SGX302 for mild-to-moderate plaque psoriasis, SGX942 for oral mucositis, and SGX945 for aphthous ulcers in Behçet’s Disease, spanning preclinical to Phase 3 and NDA review. The company also runs Public Health Solutions programs funded by the U.S. government, including RiVax to prevent ricin poisoning and ThermoVax thermostable vaccines for global use.

Parse Score

16.2
Strength0
Reach15
Authority0

Work at Soligenix?

Claim this profile for the full report: every prompt where Soligenix appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.